Document is current
Any future updates will be listed below
-
Authors
Zhang, Yingchai https://orcid.org/0000-0001-5092-4859
Tam, Claudia H. T. https://orcid.org/0000-0002-9169-0013
Lau, Eric S. H. https://orcid.org/0000-0003-1581-5643
Ng, Noel Y. H. https://orcid.org/0000-0003-4186-7113
Yang, Aimin https://orcid.org/0000-0003-2968-1762
Fan, Baoqi https://orcid.org/0000-0001-6728-419X
Wu, Hongjiang https://orcid.org/0000-0003-2193-1114
Lim, Cadmon K. P. https://orcid.org/0000-0001-5523-9199
Chow, Elaine Y. K. https://orcid.org/0000-0002-4147-3387
Luk, Andrea O. Y. https://orcid.org/0000-0002-5244-6069
Kong, Alice P. S. https://orcid.org/0000-0001-8927-6764
Tam, Wing Hung https://orcid.org/0000-0003-1189-740X
Chan, Juliana C. N. https://orcid.org/0000-0003-1325-1194
Ma, Ronald C. W. https://orcid.org/0000-0002-1227-803X
-
Funding
Funding for this research was provided by:
Research Grants Council Research Impact Fund and University Grants Committee Research Grants Matching Scheme (R4012-18)
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 17 September 2024
First Online: 29 November 2024
Acknowledgements
: YCZ acknowledges the receipt of a Vice-Chancellor’s PhD scholarship from the Chinese University of Hong Kong. YCZ acknowledges the receipt of travel support from the T1D Fellow Program of the Endocrine Society (ENDO) 2024 meeting. Part of the results have been presented at the ENDO Annual Meeting in June 2024, Boston, USA.
: Data are available from the corresponding author upon reasonable request.
: RCWM acknowledges the support provided by the Research Grants Council Research Impact Fund (R4012-18) and University Grants Committee Research Grants Matching Scheme.
: JCNC received consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Celltrion, MSD, Pfizer, Servier and Viatris Pharmaceutical, speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, MSD, Merck, Sanofi and Servier, and research grants through her institutions from Applied Therapeutics, AstraZeneca, Hua Medicine, Lee Powder, Lilly, Merck and Servier. APSK received research grants from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli-Lilly, Kyowa Kirin and Merck Serono, and honoraria for consultancy or giving lectures from Nestle, Novo Nordisk, Pfizer and Sanofi. EYKC received speaker fees from Sanofi and Novartis, and institutional research funding from Sanofi, Medtronic Diabetes and Powder Pharmaceuticals Inc. RCWM has received research funding from AstraZeneca, Bayer, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Roche Diagnostics and Tricida Inc. for carrying out clinical trials or studies, and from AstraZeneca, Bayer, Boehringer Ingelheim and Merck for speaker honoraria or consultancy in advisory boards. All proceeds have been donated to the Chinese University of Hong Kong to support diabetes research. RCWM is also a member of the editorial board of Diabetologia. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: YCZ, CHTT and RCWM were responsible for the conception and design of the study. ESHL, CKPL, APSK, WHT, JCNC and RCWM contributed to data acquisition. YCZ, CHTT, ESHL, NYHN, AY, BF, HW, EYKC, AOYL, APSK, WHT, JCNC and RCWM were involved in data interpretation. YCZ, CHTT and ESHL conducted the data analysis. RCWM had access to all the data. APSK, WHT, JCNC and RCWM contributed to funding acquisition for the datasets included in the study. YCZ and RCWM drafted the manuscript, while CHTT, ESHL, NYHN, AY, BF, EYKC, HW, CKPL, AOYL, APSK, WHT and JCNC provided critical revisions to the manuscript, providing important intellectual content. All authors read and approved the final version to be published. RCWM is the guarantor of this work.
